Artwork

Indhold leveret af Ketamine Wellness Centers. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Ketamine Wellness Centers eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Does Spravato require patients to be prescribed an antidepressant?

10:42
 
Del
 

Manage episode 229677530 series 1756689
Indhold leveret af Ketamine Wellness Centers. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Ketamine Wellness Centers eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention. This episode is about Treatment Resistant Depression and the requirements of Spravato, as such. We touch on: - The clinical definition of Treatment Resistant Depression - What to do about co-occurring conditions such as anxiety, suicidal ideation, ocd, etc? - Does Spravato require patients to be prescribed to an antidepressant to qualify for using it? - Is Spravato utilizing the full potential of Ketamine to treat Depression?
  continue reading

15 episoder

Artwork
iconDel
 
Manage episode 229677530 series 1756689
Indhold leveret af Ketamine Wellness Centers. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Ketamine Wellness Centers eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention. This episode is about Treatment Resistant Depression and the requirements of Spravato, as such. We touch on: - The clinical definition of Treatment Resistant Depression - What to do about co-occurring conditions such as anxiety, suicidal ideation, ocd, etc? - Does Spravato require patients to be prescribed to an antidepressant to qualify for using it? - Is Spravato utilizing the full potential of Ketamine to treat Depression?
  continue reading

15 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning